Back to Cancer Australia's website

Cancer Australia

Select a guideline

Recommendations for use of Bisphosphonates


Membership of the Bisphosphonates Working Group

This guideline was developed by a multidisciplinary working group convened by NBOCC*.

Dr Nick Pavlakis Medical Oncologist (Chair)
Dr Peter Barry Surgeon
Ms Denice Bassanelli Consumer Representative
Ms Sholeh Boyle Specialist Breast Nurse
Dr Roslyn Drummond Radiation Oncologist
Dr Belinda Kiely Medical Oncologist
Ms Jenny Macindoe Breast Care Nurse Coordinator
Dr Katrina Moore Surgeon
Ms Marlene Parsons Consumer Representative
Ms Geraldine Robertson Consumer Representative
Dr Bronwyn Stuckey Endocrinologist

Cancer Australia acknowledges the Breast Cancer Guideline Update Steering Committee, chaired by Dr Catherine Shannon, for their input into the development of this guideline.

Cancer Australia staff

Ms Sue Sinclair  General Manager
Ms Ornella Care Program Manager
Ms Fleur Webster Program Manager
Ms Emma Lonsdale    Project Officer
Dr Anne Nelson   Evidence Review and Research Leader
Ms Rosemary Wade  Senior Project Officer – Research

* In July 2011, National Breast and Ovarian Cancer Centre (NBOCC) amalgamated with Cancer Australia to form a single national agency, Cancer Australia, to provide leadership in cancer control and improve outcomes for Australians affected by cancer.

External review

Cancer Australia acknowledges those who gave their time to provide comment on the draft guideline recommendations as part of the external review process.

Topic-specific guideline development process

Priority topic areas for Cancer Australia guideline development are determined in consultation with key stakeholders including experts in relevant disciplines and consumer representatives. A specific multidisciplinary Working Group, including consumers, is established for each topic identified and is involved in all aspects of guideline development. A systematic evidence review is undertaken for each guideline. All members are asked to declare any conflicts of interest and these declarations are recorded.  The content of the guideline is not influenced by any external funding body. The guideline is reviewed externally by key stakeholders and the wider community and endorsement is sought from relevant professional colleges and groups in Australia.

The National Breast Cancer Foundation provided funding for the development and production of this guideline.

Published using CeCC Docbook Manager